Abiopharma

News list

📋 David Kirn (Officer) plans to sell 12K shares of 4D Molecular Therapeutics, Inc. (at $10.09 each, total $125K) Filed: Aug 03, 2026 | ID: 000473

Full text

News bot Aug. 3, 2026, 9:30 p.m.
📋 Form 144 Filing: David Kirn

Company: 4D Molecular Therapeutics, Inc.

Filing Date: 2026-08-03

Relationship: Officer
Planned Sale Details:
- Security: Class A Common
- Shares to be Sold: 12,415
- Price per Share: $10.09
- Total Value: $125,267.35
- Planned Sale Date: 2026-08-03
- Broker: Goldman Sachs & Co. LLC
- Exchange: NASD
Additional Information:
- SEC File Number: 001-39782
- Issuer Contact Phone: 1-510-505-2680
- Issuer Address: 5858 Horton Street, Suite 455, Emeryville, CA, 94608
- Broker Address: 200 West Street, New York, NY, 10282
- Shares Outstanding: 52276254.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 4
- Remarks: The sales of shares set forth herein are made in connection with a selling plan dated 01/09/2026 that is intended to comply with Rule 10b5-1(c).